Most Recent Articles by Suzanne Bujara
Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
The transition from pediatric to adult care for type 1 diabetes should be a gradual process, with a plan to make the change when the patient is ready, not at a pre-determined time.
Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.
Knowing that certain characteristics increase the risk for dermatology patients who may have metabolic syndrome will enable clinicians to identify patients who may have specific cardiovascular risks.
More Articles by Suzanne Bujara
Endocrinology Advisor Articles
- Behavioral Weight Loss Interventions May Prevent Obesity
- PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes
- Association Between Urine Complement Proteins and Kidney Disease, Mortality in T2D
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Availability and Affordability of Diabetes Medication Worldwide
- Estradiol, Cortisol, TGF-β1 Involved in Thyroid Immunity During Pregnancy and Postpartum
- Pharmacotherapy Personalization May Optimize Outcomes for Type 2 Diabetes
- Late-Onset Epilepsy Linked to Diabetes
- Examining the Ethical Considerations of Grateful Patient Fundraising
- Muscle Cell Proﬁles Relate to Exercise Response Variation in Type 2 Diabetes